Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Gelineau Syndrome

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Gelineau Syndrome in 1 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Honda, K1
Riehl, J1
Mignot, E1
Nishino, S1

Other Studies

1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Gelineau Syndrome

ArticleYear
Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected].
    Neuroreport, 1999, Sep-29, Volume: 10, Issue:14

    Topics: Animals; Arousal; Azepines; Cataplexy; Dogs; Dopamine Agonists; Electroencephalography; Electromyogr

1999